AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 284: H1398-H1407, 2003. First published January 9, 2003; doi:10.1152/ajpheart.00737.2002
0363-6135/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/4/H1398    most recent
00737.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, R.
Right arrow Articles by Li, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, R.
Right arrow Articles by Li, L.
Vol. 284, Issue 4, H1398-H1407, April 2003

Human SM22alpha BAC encompasses regulatory sequences for expression in vascular and visceral smooth muscles at fetal and adult stages

Rui Xu1, Ye-Shih Ho3, Raquel P. Ritchie2, and Li Li1,2,3

1 Department of Internal Medicine, 2 Center for Molecular Medicine and Genetics, and 3 Environmental Health Sciences Center, Wayne State University, Detroit, Michigan 48201

The SM22alpha gene has widely been used to study the regulatory mechanisms of smooth muscle cell (SMC) gene expression during cardiovascular development. To determine the regulatory mechanisms for the evolutionarily conserved human SM22alpha (hSM22alpha ) gene, we demonstrated that 445 bp upstream DNA sequences of hSM22alpha gene exhibited a high transcriptional activity in arterial SMC, not in venous nor in visceral SMCs during embryogensis. However, this promoter was gradually turned off in adulthood. Inclusion of the first intron in this promoter suppressed the promoter activity in pulmonary trunk arterial SMCs, whereas the expression in other systemic vasculature remained similar to that of the hSM22-445 promoter during the fetal and adult stages. To determine whether additional sequences are required for SM22alpha expression in all subtypes of SMCs, we examined the expression of a bacterial artificial chromosome containing the hSM22alpha locus in transgenic mice. The hSM22alpha transgene showed similar developmental expression patterns as the endogenous mouse SM22alpha gene, suggesting that this bacterial artificial chromosome contains essential regulatory sequences for its expression in arterial, venous, and visceral tissues during development.

bacterial artificial chromosome; regulatory element; intron; pulmonary trunk


This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
K. Touw, A. M. Hoggatt, G. Simon, and B. P. Herring
Hprt-targeted transgenes provide new insights into smooth muscle-restricted promoter activity
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1024 - C1032.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
P. Qiu, R. P. Ritchie, Z. Fu, D. Cao, J. Cumming, J. M. Miano, D.-Z. Wang, H. J. Li, and L. Li
Myocardin Enhances Smad3-Mediated Transforming Growth Factor-{beta}1 Signaling in a CArG Box-Independent Manner: Smad-Binding Element Is an Important cis Element for SM22{alpha} Transcription In Vivo
Circ. Res., November 11, 2005; 97(10): 983 - 991.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online